ACTU
Financials
- Market Capitalization 39.86 M
- Employee 12
- Founded 2015
- CEO N/A
- Website www.actuatetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00NK7LK03
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4327 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.87 USD | -3.61% | -4.10% | -73.21% | -80.60% | 42.41 M USD | ||
| 4344 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.25 USD | -7.41% | -13.79% | -21.88% | -85.63% | 39.92 M USD | ||
| 4354 |  CRVO CervoMed Inc. - Common Stock | 2.60 USD | -1.52% | -1.89% | +5.26% | -73.06% | 39.31 M USD | ||
| 4383 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.18 USD | -4.39% | -24.57% | -56.92% | -77.07% | 36.91 M USD |
Frequently asked questions about Actuate Therapeutics, Inc. Common stock
What is the Actuate Therapeutics, Inc. Common stock stock price today?
The current price of Actuate Therapeutics, Inc. Common stock (ACTU) is 1.66. Over the past 24 hours, the stock has changed by -1.78%. Follow the ACTU chart for real-time price dynamics.
What is the stock ticker of Actuate Therapeutics, Inc. Common stock?
Actuate Therapeutics, Inc. Common stock trades under the ticker ACTU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Actuate Therapeutics, Inc. Common stock stock going up?
ACTU has changed by +29.69% over the last week, +52.29% over the last month, and -59.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Actuate Therapeutics, Inc. Common stock?
Actuate Therapeutics, Inc. Common stock currently has a market capitalization of 39.86 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Actuate Therapeutics, Inc. Common stock earnings last quarter?
Last quarter, Actuate Therapeutics, Inc. Common stock reported earnings of -0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Actuate Therapeutics, Inc. Common stock net income for the last quarter?
Actuate Therapeutics, Inc. Common stock reported net income of -4.87 M for the last quarter. The previous quarter showed -5.63 M, which means net income changed by +13.49%.
How many employees does Actuate Therapeutics, Inc. Common stock have?
As of the latest available data, Actuate Therapeutics, Inc. Common stock has 12 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Actuate Therapeutics, Inc. Common stock stock?
You can buy Actuate Therapeutics, Inc. Common stock (ACTU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Actuate Therapeutics, Inc. Common stock stock?
Investing in Actuate Therapeutics, Inc. Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ACTU chart and related analysis on metatrader.com as part of your research.